PMVP
PMV Pharmaceuticals Inc
Price:  
1.57 
USD
Volume:  
104,112.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PMVP WACC - Weighted Average Cost of Capital

The WACC of PMV Pharmaceuticals Inc (PMVP) is 10.7%.

The Cost of Equity of PMV Pharmaceuticals Inc (PMVP) is 16.45%.
The Cost of Debt of PMV Pharmaceuticals Inc (PMVP) is 5.00%.

Range Selected
Cost of equity 14.20% - 18.70% 16.45%
Tax rate -% - -% -%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.6% - 11.8% 10.7%
WACC

PMVP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.25 2.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 14.20% 18.70%
Tax rate -% -%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 9.6% 11.8%
Selected WACC 10.7%